This study aims to evaluate the antioxidant and anti-inflammatory effects of acute and chronic consumption of two sweet orange (Citrus sinensis) varieties-'Rosy Red Valencia', which is rich in carotenoids such as lycopene, phytoene, and phytofluene, and 'Olinda Valencia', which lacks these carotenoids-in healthy adults. In this 4-week, randomized, parallel-arm clinical trial, participants will consume either 'Rosy Red Valencia' or 'Olinda Valencia' oranges daily. The study will assess the effects of sweet orange intake on markers of oxidative stress and inflammation, plasma carotenoid concentrations, gene expression in peripheral blood mononuclear cells, and gut health. Findings from this study may help identify potential health benefits associated with specific carotenoid profiles in sweet oranges and provide insights into their role in modulating inflammation and oxidative stress.
The health benefits of orange consumption have been described; however, the specific bioactive compounds responsible for these effects, as well as the underlying mechanisms of action, are not fully understood. There are several varieties of sweet oranges, each with a unique phytochemical profile and potentially distinct health-promoting properties. The 'Rosy Red Valencia' sweet orange is enriched in carotenoids such as lycopene, phytoene, and phytofluene, whereas the commonly consumed 'Olinda Valencia' contains negligible levels of these compounds. This randomized, parallel-arm clinical trial aims to evaluate and compare the antioxidant and anti-inflammatory effects of 'Rosy Red Valencia' and 'Olinda Valencia' sweet orange consumption in healthy men and women. Participants will be randomized to consume one of the two orange varieties twice daily for four weeks. The study includes both an acute phase (1-day consumption) and a chronic phase (4-week daily consumption). Blood samples will be collected at baseline, after 1 day, and after 4 weeks of consumption to assess changes in plasma carotenoid concentrations, markers of oxidative stress and inflammation, and gene expression profiles in peripheral blood mononuclear cells. Fecal samples will be collected at baseline and after 4 weeks to assess the effects on gut microbiota composition. By evaluating and comparing the biological effects of these two orange varieties, the study aims to elucidate the role of specific carotenoids in mediating the health benefits of sweet orange consumption.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Enrollment
20
The participants consume 2 'Rosy Red Valencia' sweet oranges daily for 4 weeks
The participants consume 2 'Olinda Valencia' sweet oranges daily for 4 weeks
Nutrition Department, Ragle Facility, University of California Davis
Davis, California, United States
RECRUITINGLevels of lycopene and noncolored carotenoids
Levels in plasma
Time frame: 0, 1 day, 4 weeks
Oxidative stress markers
Markers of oxidative stress in plasma/ blood cells
Time frame: 0, 1 day, 4 weeks
Inflammatory markers
Markers of inflammation in plasma
Time frame: 0, 1 day, 4 weeks
Gene expression
Gene expression in Peripheral Blood Mononuclear Cells (PBMCs)
Time frame: 0, 1 day, 4 weeks
Lipid/metabolic profile
Measured in blood samples
Time frame: 0, 4 weeks
Blood pressure
Time frame: 0, 4 weeks
Microbiota composition
From stool samples
Time frame: 0, 4 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.